Fingerprint
Dive into the research topics of 'An open-label, single-arm, phase2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically